Impact of Dapagliflozin on Intestinal Microbiota Composition and on the Metabolites Derived From the Intestinal Microbiota in Non-diabetic Chronic Renal Failure Patients
Condition: Chronic Kidney Diseases Intervention: Drug: impact of Dapagliflozin on Intestinal Microbiota on chronic renal failure patients Sponsor: Hospices Civils de Lyon Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Dapagliflozin | Diabetes | Endocrinology | Forxiga | Renal Failure | Research | Urology & Nephrology